<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 TRANSITIONAL//EN">
<HTML>
<HEAD>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; CHARSET=UTF-8">
<META NAME="GENERATOR" CONTENT="GtkHTML/4.6.4">
</HEAD>
<BODY>
I will go one step further:<BR>
<BR>
I believe that all the instances noted by Peter are not simply oversights; I believe they are part of a kind of "benign neglect" aimed at creating as much confusion as possible. The result is that researchers do not know which way to and, therefore, abstain.<BR>
<BR>
At least, if I were a strategist within one of these big publishers, this is what I would strive to do: avoid direct confrontation and muddy the waters as much as you can while optimizing the revenue stream from whatever source.<BR>
<BR>
Jean-Claude Guédon<BR>
<BR>
<BR>
Le mardi 10 décembre 2013 à 13:05 +0000, Peter Murray-Rust a écrit :
<BLOCKQUOTE TYPE=CITE>
There is a general point: the Elsevier site(s) are riddled with Open Access inconsistencies. I have discovered at least:<BR>
<BR>
<BR>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
* open access articles behind paywalls<BR>
<BR>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
* articles advertised as open access but not labelled anywhere<BR>
<BR>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
* (private correspondence) articles paid for as open access but never posted as such (espite correspondence by authors)<BR>
<BR>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
* articles without any statement of open access (IMO both the HTML and PDF should have clear statements)<BR>
<BR>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
* articles with conflicting messages (CC-BY and "All rights reserved")<BR>
<BR>
<BR>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
There are other serious deficiencies:<BR>
<BR>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
* the licence is often many pages down the paper (e.g. just before the references and very difficult to locate). It must be on the visible section of page 0.<BR>
<BR>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
* the Rightslink is seriously broken.<BR>
<BR>
<BR>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
All this gives the consistent impression (over at least a year) of an organisation which doesn't care about doing it properly and/or isn't competent to do it. It is clearly a case of retrofitting something that hasn't been prepared for, and without enough investment.<BR>
<BR>
<BR>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
The whole area Open-access provided by Toll-Access publishers cries out for a body which creates acceptable practice guidelines, monitors compliance, fines offenders and restores mispaid APCs to authors. If an author pays 5000 USD for a product they deserve better than this.<BR>
<BR>
<BR>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
Elsevier are the worst offender that I have investigated, followed by Springer who took all my Open Access images, badged them as (C) SpringerImages and offered them for resale at 60 USD per image. Just because OA is only 5% of your business doesn't mean practice can be substandard.<BR>
<BR>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
<BR>
<BR>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
On Tue, Dec 10, 2013 at 12:06 PM, Heather Morrison <<A HREF="mailto:Heather.Morrison@uottawa.ca">Heather.Morrison@uottawa.ca</A>> wrote:<BR>
<BLOCKQUOTE>
Thank you for the clarification, Alicia and Graham.<BR>
<BR>
However, on the Elsevier "copyright when publishing open access" page, it states that under the Exclusive License Agreement used with open access journals, "Elsevier is granted"..."An exclusive right to publish and distribute an article".<BR>
From: <A HREF="http://www.elsevier.com/about/open-access/open-access-policies/author-agreement">http://www.elsevier.com/about/open-access/open-access-policies/author-agreement</A><BR>
<BR>
Also the graph on this page shows a one-way distribution from publisher to user. Whoever created this graph obviously does not understand open access. There is no author to publisher (for final version) to repository to whoever option illustrated, for example, and no publisher to user to downstream user who receives article from someone other than the publisher.<BR>
<BR>
Open access means that anyone can distribute the article. Even with CC restricted licenses, the restrictions are specific to certain types of uses (e.g. can distribute but not for commercial gain - NC; can distribute but not change - ND; can distribute and create derivatives but derivatives must have the same license - SA). An article that cannot be distributed by others is not open access.<BR>
<BR>
It would be helpful to review the actual author's agreement. I don't see a link from the Elsevier site - can you point me to a link?<BR>
<BR>
best,<BR>
<BR>
Heather Morrison
</BLOCKQUOTE>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
<BLOCKQUOTE>
<BR>
On 2013-12-10, at 5:26 AM, Wise, Alicia (ELS-OXF) wrote:<BR>
<BR>
> Thank you, Graham – all correct, and more clear and concise than I would have been!<BR>
><BR>
> With kind wishes,<BR>
> Alicia<BR>
><BR>
> Dr Alicia Wise<BR>
> Director of Access and Policy<BR>
> Elsevier I The Boulevard I Langford Lane I Kidlington I Oxford I OX5 1GB<BR>
> M: <A HREF="tel:%2B44%20%280%29%207823%20536%20826">+44 (0) 7823 536 826</A> I E: <A HREF="mailto:a.wise@elsevier.com">a.wise@elsevier.com</A><BR>
> Twitter: @wisealic<BR>
><BR>
> From: <A HREF="mailto:goal-bounces@eprints.org">goal-bounces@eprints.org</A> [mailto:<A HREF="mailto:goal-bounces@eprints.org">goal-bounces@eprints.org</A>] On Behalf Of Graham Triggs<BR>
> Sent: Tuesday, December 10, 2013 1:31 AM<BR>
> To: Global Open Access List (Successor of AmSci)<BR>
> Subject: [GOAL] Re: Elsevier is taking down papers from Academia.edu<BR>
><BR>
> On 9 December 2013 00:20, Heather Morrison <<A HREF="mailto:Heather.Morrison@uottawa.ca">Heather.Morrison@uottawa.ca</A>> wrote:<BR>
> Alicia,<BR>
><BR>
> According to your statement below, with CC-BY the only restriction placed by Elsevier is for attribution. However, the Elsevier open access license policy clearly states that Elsevier demands an exclusive license to publish with open access works (including CC-BY). Can you explain this discrepancy?<BR>
><BR>
> I don't believe this is a discrepancy. What it is saying that the definitive record is published by Elsevier, and the author provides an exclusive licence in order to do so.<BR>
><BR>
> Re-publishing, or re-distributing via any other venue constitutes a derivative work, which is permissible and does not conflict with the exclusive licence (which is only on the definitive record, not the derivative) - providing the proper attribution is in place.<BR>
><BR>
> Without the exclusive licence to the definitive record, then as the author retains copyright, then in theory the author could authorize publishing of a version of the definitive record without attribution to the Elsevier version.<BR>
><BR>
> It's a question of preserving the version of record. The difference between the author providing a licence to Elsevier to distribute an article under CC-BY, and the author providing a CC-BY licence to Elsevier.<BR>
><BR>
> Comment: Based on this wording it is clear that Elsevier is requiring an exclusive publishing license. This is not compatible with your explanation below that nothing is required beyond attribution as required by the CC-BY license.<BR>
><BR>
> It is consistent - the article can be re-published elsewhere, providing it is accordance with the CC-BY licence, including attribution to the definitive record as published by Elsevier.<BR>
><BR>
> G<BR>
><BR>
<BR>
</BLOCKQUOTE>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
<BLOCKQUOTE>
> Elsevier Limited. Registered Office: The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, United Kingdom, Registration No. 1982084, Registered in England and Wales.<BR>
><BR>
<BR>
</BLOCKQUOTE>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
<BLOCKQUOTE>
> _______________________________________________<BR>
> GOAL mailing list<BR>
> <A HREF="mailto:GOAL@eprints.org">GOAL@eprints.org</A><BR>
> <A HREF="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal">http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</A><BR>
<BR>
--<BR>
Dr. Heather Morrison<BR>
Assistant Professor<BR>
École des sciences de l'information / School of Information Studies<BR>
University of Ottawa<BR>
<BR>
<A HREF="http://www.sis.uottawa.ca/faculty/hmorrison.html">http://www.sis.uottawa.ca/faculty/hmorrison.html</A><BR>
<A HREF="mailto:Heather.Morrison@uottawa.ca">Heather.Morrison@uottawa.ca</A><BR>
<BR>
<BR>
<BR>
_______________________________________________<BR>
GOAL mailing list<BR>
<A HREF="mailto:GOAL@eprints.org">GOAL@eprints.org</A><BR>
<A HREF="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal">http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</A><BR>
<BR>
</BLOCKQUOTE>
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
<BR>
<BR>
<BR>
-- <BR>
Peter Murray-Rust<BR>
Reader in Molecular Informatics<BR>
Unilever Centre, Dep. Of Chemistry<BR>
University of Cambridge<BR>
CB2 1EW, UK<BR>
+44-1223-763069
</BLOCKQUOTE>
<BLOCKQUOTE TYPE=CITE>
<PRE>
_______________________________________________
GOAL mailing list
<A HREF="mailto:GOAL@eprints.org">GOAL@eprints.org</A>
<A HREF="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal">http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</A>
</PRE>
</BLOCKQUOTE>
<BR>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%">
<TR>
<TD>
--
<PRE>
Jean-Claude Guédon
Professeur titulaire
Littérature comparée
Université de Montréal
</PRE>
</TD>
</TR>
</TABLE>
</BODY>
</HTML>